DAIICHI SANKYO CO. LTD.DAIICHI SANKYO CO. LTD.DAIICHI SANKYO CO. LTD.

DAIICHI SANKYO CO. LTD.

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.12EUR
Revenue estimate
‪2.35 B‬EUR
Market capitalization
‪54.72 B‬EUR
‪1.23 B‬EUR
‪9.81 B‬EUR
‪1.65 B‬
Beta (1Y)
1.01

About DAIICHI SANKYO COMPANY LIMITED

CEO
Sunao Manabe
Headquarters
Tokyo
Founded
2005
FIGI
BBG000DXRNN7
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange DAIICHI SANKYO CO. LTD. stocks are traded under the ticker D4S.
DAIICHI SANKYO CO. LTD. is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
D4S earnings for the last quarter are 0.22 EUR per share, whereas the estimation was 0.11 EUR resulting in a 104.46% surprise. The estimated earnings for the next quarter are 0.05 EUR per share. See more details about DAIICHI SANKYO CO. LTD. earnings.
DAIICHI SANKYO CO. LTD. revenue for the last quarter amounts to ‪2.87 B‬ EUR despite the estimated figure of ‪2.62 B‬ EUR. In the next quarter revenue is expected to reach ‪2.49 B‬ EUR.
Yes, you can track DAIICHI SANKYO CO. LTD. financials in yearly and quarterly reports right on TradingView.
D4S net income for the last quarter is ‪227.58 M‬ EUR, while the quarter before that showed ‪427.37 M‬ EUR of net income which accounts for −46.75% change. Track more DAIICHI SANKYO CO. LTD. financial stats to get the full picture.
DAIICHI SANKYO CO. LTD. dividend yield was 1.05% in 2023, and payout ratio reached 47.76%. The year before the numbers were 0.62% and 52.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, D4S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAIICHI SANKYO CO. LTD. stock right from TradingView charts — choose your broker and connect to your account.
D4S reached its all-time high on Jun 12, 2023 with the price of 34.300 EUR, and its all-time low was 3.725 EUR and was reached on Dec 16, 2014.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on DAIICHI SANKYO CO. LTD. future price: according to them, D4S price has a max estimate of 37.73 EUR and a min estimate of 25.16 EUR. Read a more detailed DAIICHI SANKYO CO. LTD. forecast: see what analysts think of DAIICHI SANKYO CO. LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAIICHI SANKYO CO. LTD. EBITDA is ‪1.49 B‬ EUR, and current EBITDA margin is 15.22%. See more stats in DAIICHI SANKYO CO. LTD. financial statements.